Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion

Central retinal vein occlusion (CRVO) is a relatively common retinal vascular disorder in which macular oedema may develop, with a consequent reduction in visual acuity. Until recently there has been no treatment of proven benefit, but growing evidence supports the use of anti-vascular endothelial growth factor (anti-VEGF) agents.To investigate the effectiveness and safety of anti-VEGF therapies for the treatment of macular oedema secondary to...